| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/25/2006 | EP1490363B1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 01/25/2006 | EP0978392B1 Optical recording media |
| 01/25/2006 | EP0697872B1 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726215A [1,7]naphthyridines as PDE4 inhibitors |
| 01/25/2006 | CN1726214A Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 01/25/2006 | CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 01/25/2006 | CN1726212A Pre-organized tricyclic integrase inhibitor compounds |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1726031A 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines |
| 01/25/2006 | CN1724539A Purification method of catharanthine and vincristine |
| 01/25/2006 | CN1724538A Method of chromatography preparing high purity catharanthine sulphate by continuous medium pressure column |
| 01/24/2006 | US6989449 Containing nitroxide or hydroxylamine moieties; use stabilizing pulp or paper against yellowing and discoloration due to light |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989389 Immunomodulators; tetrahydroimidazo[4,5-c]quinoline-4-amine-1-(alkynyloxyalkyl) derivatives; induce cytokines biosynthesis; antitumor agents, viral diseases |
| 01/24/2006 | US6989386 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | CA2261923C Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 01/19/2006 | WO2006005974A1 A process for the preparation of risperidone |
| 01/19/2006 | WO2006005853A1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 01/19/2006 | WO2006005726A2 Heterocyclic compounds |
| 01/19/2006 | WO2006005725A2 N containing condensed heterocycles with antitumor effects |
| 01/19/2006 | WO2005105805A9 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/19/2006 | WO2005097129A3 6-azaindole compound |
| 01/19/2006 | WO2005070930A3 Tetrahydrocarboline compounds as anticancer agents |
| 01/19/2006 | US20060014951 4-amino-substituted pyrimidine derivatives |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014778 (+-)-cis 6-Methoxy-8-phenyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,4-c]quinoline; serotonin receptor modulators; obesity, diabetes, atherosclerosis, dyslipidemia; central nervous system diseases like anxiety, depression, OCD, panic disorder, psychosis, schizophrenia, sleep and sexual disorders, |
| 01/19/2006 | US20060014777 Pyrrolo(oxo)isoquinolines as 5HT ligands |
| 01/19/2006 | US20060014776 Antitumoral compounds |
| 01/19/2006 | US20060014772 Phenanthroindolizidine alkaloids |
| 01/19/2006 | US20060014765 For therapy of, for example, transplant rejection, inflammatory bowel syndrome, rheumatoid arthritis, psoriasis, restenosis, allergic asthma, Alzheimer's disease, Parkinson, stroke, osteoporosis, cancer, and benign hyperplasia |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014748 2-NH-heteroarylimidazoles with antibacterial activity |
| 01/19/2006 | US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/19/2006 | US20060014682 Chemokine receptor antagonist peptide with a sequence homologous to SDF-1 wherein at least one amino acid at positions five to eight are substituted with proline; proliferative agents; self-regeneration of stem cells |
| 01/19/2006 | CA2571491A1 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 01/19/2006 | CA2568993A1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 01/18/2006 | EP1615944A2 Antiandrogens with marginal agonist activity and methods of use |
| 01/18/2006 | EP1615925A1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 01/18/2006 | EP1615924A1 Water soluble salts of risperidone |
| 01/18/2006 | EP1615923A1 Risperidone monohydrochloride |
| 01/18/2006 | EP1615922A1 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them |
| 01/18/2006 | EP1615921A2 Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 01/18/2006 | EP1615919A1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1615645A1 A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
| 01/18/2006 | EP1615643A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | EP0973727B8 Activated iododerivatives for the treatment of cancer and aids |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
| 01/17/2006 | US6987187 Process for preparation of amidine derivatives |
| 01/17/2006 | US6987186 Synthesis of small particle size quinacridone of beta crystal phase |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987115 Treating bacterial infections with a 1,2,3,4-tetrahydrobeta-carbolin-2-yl-alkyl-1-one; chemical intermediates, amidation |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | CA2300069C Naphthalimidobenzamide derivatives |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/12/2006 | WO2006004925A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2006004884A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 01/12/2006 | WO2006004833A2 Pyrrolotriazine kinase inhibitors |
| 01/12/2006 | WO2006004702A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
| 01/12/2006 | WO2006004636A2 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | WO2006003440A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 01/12/2006 | WO2006003090A1 Fluorescent quinacridones |
| 01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | WO2005060959A8 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 01/12/2006 | WO2004089951A8 Imidazopyridine derivatives having an affinity for melanocortin receptors |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009471 Amido compounds and their use as pharmaceuticals |
| 01/12/2006 | US20060009465 Treatment of sleep disorders using sleep target modulators |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572083A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 01/12/2006 | CA2572058A1 Azaindoles useful as inhibitors of protein kinases |
| 01/12/2006 | CA2571680A1 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | CA2571588A1 Pyrazolopyridine derivatives |
| 01/12/2006 | CA2570319A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |